{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:50:59Z","timestamp":1762451459427,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Development Program of North Sichuan Medical College","award":["CBY16-A-ZD10"],"award-info":[{"award-number":["CBY16-A-ZD10"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Data in Brief"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.dib.2018.06.091","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T19:02:22Z","timestamp":1530385342000},"page":"448-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An up-dated meta-analysis of major adverse cardiac events on triple versus dual antiplatelet therapy after percutaneous coronary intervention in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-2712","authenticated-orcid":false,"given":"Mao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dib.2018.06.091_bib1","first-page":"931","article-title":"Long-term effect of triple antiplatelet therapy for diabetic patients after percutaneous coronary intervention","volume":"33","author":"Zang","year":"2008","journal-title":"Med. J. Chin. People\u05f3S. Lib. Army"},{"key":"10.1016\/j.dib.2018.06.091_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ahj.2009.01.006","article-title":"Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study","volume":"157","author":"Han","year":"2009","journal-title":"Am. Heart J"},{"key":"10.1016\/j.dib.2018.06.091_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.amjcard.2007.05.032","article-title":"and Investigators DE-LS. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial)","volume":"100","author":"Lee","year":"2007","journal-title":"Am. J Cardiol."},{"key":"10.1016\/j.dib.2018.06.091_bib4","first-page":"35","article-title":"Study of using cilostazol for preventing restenosis after stenting in patients with diabetes mellitus","volume":"15","author":"Lu","year":"2007","journal-title":"Chin. J. Diabetes"},{"key":"10.1016\/j.dib.2018.06.091_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2007.11.049","volume":"51","author":"Lee","year":"2008","journal-title":"J Am. Coll. Cardiol."},{"key":"10.1016\/j.dib.2018.06.091_bib6","first-page":"426","article-title":"Efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention","volume":"19","author":"Li","year":"2010","journal-title":"Chin. J. Cardiovasc. Rehabil. Med."},{"key":"10.1016\/j.dib.2018.06.091_bib7","first-page":"566","article-title":"Long-term effect of triple antiplatelet therapy for treatment of patients with diabetes and acute coronary syndrome after drug-eluting stent implantation","volume":"33","author":"Shen","year":"2010","journal-title":"Shanghai Med. J."},{"key":"10.1016\/j.dib.2018.06.091_bib8","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2010.10.035","volume":"57","author":"Lee","year":"2011","journal-title":"J Am. Coll. Cardiol."},{"key":"10.1016\/j.dib.2018.06.091_bib9","first-page":"1334","article-title":"Impact of triple anti-platelet therapy on activation of platelet and short-term outcomes in CHD patients with diabetes undergoing PCI","volume":"29","author":"Gao","year":"2014","journal-title":"Clin. Focus."}],"container-title":["Data in Brief"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235234091830742X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235234091830742X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:46:36Z","timestamp":1762451196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235234091830742X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":9,"alternative-id":["S235234091830742X"],"URL":"https:\/\/doi.org\/10.1016\/j.dib.2018.06.091","relation":{},"ISSN":["2352-3409"],"issn-type":[{"type":"print","value":"2352-3409"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An up-dated meta-analysis of major adverse cardiac events on triple versus dual antiplatelet therapy after percutaneous coronary intervention in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Data in Brief","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dib.2018.06.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}